Astex Pharmaceuticals is a world leader in innovative drug discovery and development. The company has successfully applied its proprietary fragment-based drug discovery platform to generate multiple new drug candidates that are progressing in clinical development. Successful collaborations have led to two launched oncology drugs (Kisqali® partnered with Novartis and Balversa® partnered with Janssen). Our continued investment in new technologies such as CryoEM and bioinformatics has provided new opportunities for drug discovery in both oncology and neurodegenerative disease. We are now looking to broaden our capabilities in the Bioscience area to exploit this investment and drive our drug discovery portfolio forward. To find out more please visit our career website